Unknown

Dataset Information

Improved kidney function is associated with Colchicine treatment in COVID-19 patients.


ABSTRACT:

Background

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus) has been a major cause of significant morbidity and mortality. Acute kidney injury (AKI) has been seen in COVID-19-infected subjects, and it has frequently resulted in an abnormal estimated glomerular filtration rate. Colchicine, an immunomodulatory drug, was used in several studies in the early stages of the pandemic. Colchicine has been shown to prevent the development of renal failure in patients with Familial Mediterranean Fever (FMF). It has also been reported to reduce fibrosis, which plays a role in chronic kidney disease. We, therefore, aimed to investigate whether using Colchicine, in addition to standard care, was associated with better renal function in patients with severe COVID-19 infecti

SUBMITTER: Bayram YE 

PROVIDER: S-EPMC11556156 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature